Results 91 to 100 of about 1,194,975 (181)

Overcoming differences: The catalytic mechanism of metallo-β-lactamases [PDF]

open access: yes, 2015
Metallo-β-lactamases are the latest resistance mechanism of pathogenic and opportunistic bacteria against carbapenems, considered as last resort drugs. The worldwide spread of genes coding for these enzymes, together with the lack of a clinically useful ...
Llarrull, Leticia Irene   +2 more
core   +1 more source

Interpretation of Key Updates in the 36th Edition of Clinical and Laboratory Standards Institute M100 Standard

open access: yesiLABMED, Volume 4, Issue 3, Page 133-138, September 2026.
ABSTRACT The Clinical and Laboratory Standards Institute M100 document serves as a cornerstone standard for clinical microbiology laboratories in China. Maintaining the scientific rigor of its predecessors, the 36th edition incorporates updated epidemiological cutoff values, pharmacokinetic/pharmacodynamic data, and clinical efficacy evidence to revise
Kanghong Xu, Qi Wang, Hui Wang
wiley   +1 more source

Antarctic soil microbiomes encode structurally conserved and phylogenetically diverse beta‐lactamases

open access: yesiMetaOmics, Volume 3, Issue 3, September 2026.
An integrative metagenomic framework combining sequence, structural, and functional inference reveals a phylogenetically diverse and structurally conserved repertoire of putative beta‐lactamases across Antarctic soil microbiomes, with predominance of class A and subclass B3 enzymes and limited but detectable associations with mobile genetic elements ...
José Coche‐Miranda   +8 more
wiley   +1 more source

A protein structure-guided covalent scaffold selectively targets the B1 and B2 subclass metallo-β-lactamases

open access: yes, 2018
We report the discovery of ebselen-based dual covalent inhibitors of metallo-β-lactamases.
Ying Ge   +7 more
core   +1 more source

Rh(III)-catalyzed directed C–H carbenoid coupling reveals aromatic bisphosphonates inhibiting metallo- and Serine-β-lactamases [PDF]

open access: yes, 2018
We report the highly efficient and scalable Rh(III)-catalyzed C–H coupling of arenes with diazo-methylene-diphosphonates to give structurally diverse aromatic bisphosphonates in good to excellent yields.
Yan-chi Pu   +8 more
core   +1 more source

Investigating enzyme function by geometric matching of catalytic motifs

open access: yesProtein Science, Volume 35, Issue 9, September 2026.
Abstract The rapidly growing universe of predicted protein structures offers opportunities for data driven exploration but requires computationally scalable and interpretable tools. We developed a method to detect catalytic features in protein structures, providing insights into enzyme function and mechanism.
Raymund E. Hackett   +5 more
wiley   +1 more source

β-lactamase-mediated resistance in MDR-Pseudomonas aeruginosa from Qatar

open access: yesAntimicrobial Resistance and Infection Control, 2020
Background The distribution of β-lactam resistance genes in P. aeruginosa is often closely related to the distribution of certain high-risk international clones.
Mazen A. Sid Ahmed   +6 more
doaj   +1 more source

Metagenomics Reveals Microbial Community Shifts Associated With Contrasting Anthropogenic Impacts in Freshwater Sources of A Coastal Protected Area in Southeastern Brazil

open access: yesWater Environment Research, Volume 98, Issue 9, September 2026.
Metagenomics revealed distinct anthropogenic signatures in the microbiome of freshwater sources on Marambaia Island, supported by the Anthropogenic Impact Index (AII). Impacted sites showed lower microbial diversity, enrichment of fecal‐associated taxa, and 14 antimicrobial resistance genes, whereas conductivity, salinity, and turbidity explained 88.1%
Bruna Barbosa de Paula   +6 more
wiley   +1 more source

New Delhi metallo-β-lactamase-1 catalyses avibactam and aztreonam hydrolysis. [PDF]

open access: yes, 2017
Metallo-β-lactamases (MBLs) threaten the clinical utility of β-lactam antibiotics by hydrolysing penicillins, cephalosporins, and ...
Christopher T. Lohans   +2 more
core   +1 more source

A Four‐Center Study on the Activity of Aztreonam and Aztreonam‐Avibactam Combination Against Clinical Isolates of Gram‐Negative Bacilli Producing Representatives of Ambler Class A, B, C or D β‐Lactamases

open access: yesAPMIS, Volume 134, Issue 9, September 2026.
ABSTRACT We aimed to investigate the activity of aztreonam and aztreonam‐avibactam combination against gram‐negative bacilli producing different types of β‐lactamases. Activity of aztreonam and aztreonam‐avibactam against 166 isolates (33 AmpC‐producing, 33 ESBL‐producing, 66 carbapenemase‐producing Enterobacterales, 34 metallo‐β‐lactamase‐producing P.
Gizem İnce Ceviz   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy